Table 6 Multivariate Cox regression analysis for 500 days’ cardiac events

From: Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure

Above-median value vs. below-median value

HR

95% CI

P-value

Model 1

 FGF23 (pg ml−1)

1.05

1.02–1.08

0.001

 BNP (pg ml−1)

1.00

0.99–1.00

0.934

Model 2

 FGF23 (pg ml−1)

1.06

1.03–1.10

<0.001

 BNP (pg ml−1)

1.00

0.99–1.00

0.903

  1. Abbreviations: BNP, B-type natriuretic peptide; CI, confidence interval; eGFR, estimated glomerular filtration rate; FGF23, fibroblast growth factor 23; HR, hazard ratio.
  2. Model 1 was unadjusted. Model 2 was adjusted for age, sex and eGFR.